Q3 2018
|
10 |
425,478 |
AVRO, NSTG, SIEN, FTSV
|
13F-HR
|
11/14/2018 |
000101297518001218 |
Q2 2018
|
8 |
281,152 |
AVRO, FTSV, NSTG, SIEN
|
13F-HR
|
8/14/2018 |
000101297518001015 |
Q1 2018
|
6 |
97,783 |
NSTG, SIEN, VERO, VBIV
|
13F-HR
|
4/25/2018 |
000101297518000363 |
Q4 2017
|
6 |
100,450 |
SIEN, NSTG, VERO, VBIV
|
13F-HR
|
2/12/2018 |
000101297518000148 |
Q3 2017
|
5 |
122,849 |
NSTG, SIEN, VBIV, CATB
|
13F-HR
|
11/13/2017 |
000101297517000819 |
Q2 2017
|
5 |
108,786 |
NSTG, SIEN, VBIV, CATB
|
13F-HR
|
8/3/2017 |
000101297517000583 |
Q1 2017
|
6 |
134,358 |
NSTG, SIEN, VBIV, Oxford Immunotec Global PLC
|
13F-HR
|
5/9/2017 |
000101297517000369 |
Q4 2016
|
6 |
151,819 |
NSTG, SIEN, Oxford Immunotec Global PLC, CATB
|
13F-HR
|
2/13/2017 |
000101297517000112 |
Q3 2016
|
6 |
162,721 |
NSTG, Oxford Immunotec Global PLC, SIEN, CATB
|
13F-HR
|
11/9/2016 |
000143143116000004 |
Q2 2016
|
6 |
114,306 |
NSTG, Oxford Immunotec Global PLC, SIEN, VBIV
|
13F-HR
|
8/4/2016 |
000143143116000003 |
Q1 2016
|
6 |
133,202 |
NSTG, Oxford Immunotec Global PLC, SIEN, CATB
|
13F-HR
|
4/22/2016 |
000101297516001176 |
Q4 2015
|
7 |
142,695 |
NSTG, Oxford Immunotec Global PLC, CATB, SIEN
|
13F-HR
|
1/25/2016 |
000101297516000929 |
Q3 2015
|
8 |
173,884 |
NSTG, Oxford Immunotec Global PLC, SIEN, CATB
|
13F-HR
|
11/12/2015 |
000143143115000002 |
Q2 2015
|
7 |
227,411 |
SIEN, NSTG, CATB, Oxford Immunotec Global PLC
|
13F-HR
|
7/30/2015 |
000101297515000565 |
Q1 2015
|
7 |
240,546 |
ISEE, SIEN, NSTG, Oxford Immunotec Global PLC
|
13F-HR
|
5/12/2015 |
000101297515000327 |
Q4 2014
|
8 |
350,285 |
Aerie Pharmaceuticals Inc., ISEE, NSTG, SIEN
|
13F-HR
|
2/12/2015 |
000143143115000001 |
Q3 2014
|
6 |
250,614 |
Aerie Pharmaceuticals Inc., ISEE, NSTG, Oxford Immunotec Global PLC
|
13F-HR
|
11/13/2014 |
000143143114000009 |
Q2 2014
|
5 |
281,653 |
Aerie Pharmaceuticals Inc., ISEE, NSTG, Oxford Immunotec Global PLC
|
13F-HR
|
8/12/2014 |
000143143114000007 |
Q1 2014
|
5 |
345,617 |
ISEE, NSTG, Aerie Pharmaceuticals Inc., Oxford Immunotec Global PLC
|
13F-HR
|
5/9/2014 |
000143143114000004 |
Q4 2013
|
6 |
353,882 |
ISEE, NSTG, Aerie Pharmaceuticals Inc., Oxford Immunotec Global PLC
|
13F-HR
|
2/14/2014 |
000143143114000002 |